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Abstract
Culture confirmation of Shiga toxin-producing Escherichia coli (STEC) is very important for epidemiologic analysis. However, isolation
of non-O157 STEC on conventional selective media such as sorbitol–MacConkey agar (SMAC) can be difficult because of heavy growth of
competing bacteria and its phenotypical similarity to commensal nonpathogenic E. coli. An acid enrichment procedure was introduced in this
study to facilitate detection of STEC from patients who were symptomatic. Forty-seven clinical fecal broths, which tested positive for Shiga
toxin by commercial immunoassay, were processed for the isolation of STEC by both conventional and the acid enrichment methods. The
acid enrichment method and conventional culture recovered STEC from 91% (43/47) and 70% (33/47) of the fecal broths, respectively.
Neither method retrieved STEC in 3 specimens. Thirty-six STEC were successfully serogrouped, which included O26 (n = 11), O157 (n = 9),
O103 (n = 7), O121 (n = 3), O111 (n = 2 each), O28AC, O146, O76, and O undetermined (n = 1 each). The analysis of STEC isolates by real-
time PCR indicated that all 9 E. coli O157 contained stx2 gene alone or in combination with stx1. Non-O157 STEC more frequently
contained stx1 only, and about one-third possessed stx2. The novel acid enrichment protocol greatly reduced the growth of competitor
colonies on RTN and TCSMAC. The study demonstrated that incorporation of an acid enrichment procedure in clinical testing improved the
isolation of STEC in fecal specimens.
Published by Elsevier Inc.
Keywords: Shiga-Toxin Producing E. Coli (STEC); Acid Enrichment; Clinical fecal specimens; Rainbow agar plus tellurite and novobiocin (RTN); Sorbitol
MacConkey agar plus cefixime and tellurite (TCSMAC); Enzyme Immunoassay (EIA)
1. Introduction
Culture confirmation of Shiga toxin-producing Escheri-
chia coli (STEC) is very important for epidemiologic
purposes. Non-O157 STEC have been nationally notifiable
since 2000 and O157:H7 STEC since 1987 (Anonymous,
2006). Historically, fewer non-O157 STEC infections are
reported due in part to a lack of effective cultural methods to
detect the multiple serotypes comprising the STEC group.
Although detection of non-O157 serotypes is difficult, some
studies have shown non-O157 STEC infections represent over
50% of laboratory-confirmed STEC cases and caused
illnesses that range from mild diarrhea to bloody diarrhea,
hemorrhagic colitis, and hemolytic–uremic syndrome (HUS)
(Anonymous, 2007; Brooks et al., 2005; Fey et al., 2000;
Jelacic et al., 2003).
Clinical laboratories typically use sorbitol–MacConkey
(SMAC) agar, a culture method, to identify STEC O157,
which cannot ferment sorbitol and therefore forms colorless
colonies. However, most non-O157 STEC strains ferment
sorbitol and form pink colonies like intestinal flora. There-
fore, SMAC cannot be used to readily differentiate between
sorbitol-fermenting non-O157 STEC strains and other
sorbitol-fermenting intestinal flora growing on the plate.
Typically, the identification of O157 and non-O157 has been
facilitated by enzyme immunoassay (EIA) and/or optical
immunoassay (Kehl et al., 1997; Stapp et al., 2000; Teel
et al., 2007). However, recent studies have highlighted the
importance of culture confirmation in STEC infections
(Anonymous, 2007; Brooks et al., 2005; Fey et al., 2000;
Jelacic et al., 2003). Procedures to improve the culture
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confirmation of both O157 and non-O157 STEC would be
important to speed the outbreak investigations.
No single selective agar is effective for all STEC. Klein
et al. (2002) reported that sole reliance on SMAC screening
would have resulted in 28% underreporting of STEC, and
sole reliance on EIAwould have underdetected E. coli O157:
H7 by 11%. TCSMAC, Rainbow agar, CHROMagar, and
O157:H7ID agars are all designed primarily for detection of
O157:H7 (Bettleheim, 2005). Even when only O157:H7 is
being sought, Pao et al. (2005) reported successful recovery
from spiked feces only when inoculation levels were N105
CFU/g using SMAC and N103 CFU/g using TCSMAC.
Isolation failures at lower levels were attributed to over-
growth by nontarget competitor microorganisms.
The reduction of background microflora with concomi-
tant improvement in STEC detection has been reported in
food and water samples using a 2-step acid enrichment
protocol (Grant, 2004, 2005, 2008). A modification of this
method was evaluated using overnight enrichments of fecal
broths which tested Shiga toxin (Stx)-positive by EIA.
2. Materials and methods
2.1. Conventional analysis
Fecal broth culture specimens from clinical laboratories
were sent to the Washington State Public Health Laboratories
(WAPHL) if the culture tested positive for Stx by EIA at the
submitting laboratories. At WAPHL, conventional analyses
of these specimens include the qualitative detection of Stx1
and Stx2 using ImmunoCard STAT!EHEC (Meridian
Diagnostics, Cincinnati, OH), and/or Premier™ EHEC
(Meridian Diagnostics, Cincinnati, OH). The samples are
also streaked onto SMAC agar and MacConkey agar (MAC)
to screen for typical sorbitol-negative colonies. When only
sorbitol-positive colonies are present on SMAC agar, sets of
10 additional colonies are analyzed until 20 total colonies
from each specimen are tested for Stx using ImmunoCard
STAT!EHEC. Premier™ EHEC kit would be used if there are
many specimens. Stx-positive isolates are then serogrouped.
2.2. Shiga toxin test
The Stx test was performed following manufacturer's
instructions. Briefly, for ImmunoCard STAT!EHEC, 150 μL
of the diluted enrichment fecal broth was added to the
sample port of the card with incubation of the test at 20–25
°C for 20 min. The results were then read within 1 min after
incubation. For Premier™ EHEC, 100 μL of diluted
enrichment broth was added to the appropriate microwell,
and the plate then incubated at 20–25 °C for 1 hour. The
wells were washed 5 times with washing buffer. Then, the
detection antibody was added and mixed by shaking the
plate for 30 s. The wash procedure was repeated, and 2
drops of enzyme conjugate were added and mixed by
shaking for 30 s. Incubate the plate for 30 min at 20–25 °C.
Repeat the wash procedure, add 2 drops of substrate solution
II to each well, shake the plate for 30 s, incubate for 10 min
at 20–25 °C; add 2 drops of Stop Solution II to each well,
shake the plate for 30 s. Observe the reactions visually
within 15 min after adding Stop Solution II.
2.3. Serotyping
The E. coli OK antisera were purchased from Statens
Serum Institut/MiraVista Diagnostics (Indianapolis, IN).
Serotyping was performed according to the manufacturer's
instruction. Briefly, a single colony of overnight culture of
E. coli was mixed with a drop of antiserum on a glass slide.
The reaction was then read in 5–10 s. A positive reaction is
seen as a visible agglutination. A negative reaction is the
persistence of the homogeneous milky turbidity. Late or
weak agglutination reaction is considered negative. The
isolates that could not be typed using the available antisera
were sent to CDC for further characterization.
2.4. Acid enrichment procedure
The experimental acid enrichment procedure used TSB/
3.00 and TYTP. TSB/3.00 is the acid enrichment medium
and was prepared by adding concentrated HCl to trypticase
soy broth (TSB, Becton Dickinson, Sparks, MD) to a final
pH of 3.0 (approximately 5.3 mL/L). TYTP is the
neutralization/growth medium used in these experiments.
TYTP contained trypticase soy broth plus 12 g/L yeast
extract (Becton Dickinson), 12.5 g/L TRIS crystallized free
base (Fisher, Fair Lawn, NJ), and 1 g/L sodium pyruvate
(Sigma-Aldrich, St. Louis, MO). The pH of TYTP was
approximately pH 8.7. TSB/3.00 was sterilized by autoclav-
ing at 121 °C for 10 min and TYTP was sterilized by
autoclaving at 121 °C for 15 min.
The acid enrichment procedure is a modification of
method described by Grant (2005). Briefly, 1 mL of fecal
broth culture was added to 9 mLTSB/3.00. This was held at
20–25 °C for 30 min and then combined with 10 mL of
TYTP, which had been prewarmed to 42 °C. The contents
were mixed thoroughly and incubated at 42 °C overnight
(typically 20–22 h) without shaking. The resulting enrich-
ment culture was then evaluated by spreading onto Rainbow
agar (Biolog, Hayward, CA) with 0.8 mg L−1 tellurite and
10 mg L−1 novobiocin (RTN), in addition to TCSMAC, and
these plates were incubated at 35–37 °C for 24 h. Sets of
5 gray, black, purple, or magenta colonies from RTN agar, or
clear or pink colonies from TCSMAC agar plates, were
selected for real-time PCR analysis of the Stx-encoding genes
stx1 and stx2 (Sharma and Dean-Nystrom, 2003). For the
experiments described in Table 2, a comparison of enrich-
ments was made by placing 1-mL volumes of submitted GN
broth cultures into 99 mL fresh GN broth and incubating
overnight at 42 °C. To prepare DNA templates for real-time
PCR analysis of stx1 and stx2 genes, 1 mL volume from each
enrichment broth was pelleted by centrifugation, the super-
natant was removed, and the cell pellets was resuspended in
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100 μL of sterile nuclease free water and then boiled for 10
min. Viable counts of stx-positive colonies were determined
by randomly selecting approximately 20 presumptive
positive colonies from plates prepared from each fecal broth
and analyzing each colony individually for stx by real-time
PCR, and thenmultiplying the percent positive by total count.
2.5. Real-time PCR detection of STEC
Real-time PCR was performed using an ABI 7500
platform (Applied Biosystems, Foster City, CA) as described
previously (Sharma and Dean-Nystrom, 2003). The primers
used for stx1 include stx1-forward (5′ GACTGCAAA-
GACGTATGTAGATTCG 3′), stx1-reverse (5′ ATC-
TATCCCTCTGACATCAACTGC 3′), and stx-1 probe (5′
FAM-TGAATGTCATTCGCTCTGCAATAGGTACTC- 3′).
The primers used for stx2 include stx-2 forward
(5′ ATTAACCACACCCCACCG 3′), stx-2 reverse (5′
GTCATGGAAACCGTTGTCAC 3′), and stx-2 probe (5′
VIC-CAGTTATTTTGCTGTGGATATACGAGGGCTTG-
3′). The quencher dye TAMRA (6-carboxytetramethyl-
rhodamine) was attached to the 3′ ends of the probes.
Primers and probes were synthesized by Integrated DNA
technologies (Coralville, IA). Reaction was performed in a
final volume of 25 μL consisting of 12.5 μL of 2× PCR
Supermix (Invitrogen, Carlsbad, CA), 0.75 μL of each
primers (10 μmol/L), 0.25 μL of each probe (10 μmol/L),
2 μL cell suspension, and 7 μL of nuclease-free water. The
cycling conditions were 95 °C for 10 min followed by 40
cycles of 94 °C for 20 s, 55 °C for 30 s, and 72 °C for 45 s.
Fluorescence data were collected during the 72 °C stages
using the channels for ROX (the reference dye), FAM
(stx1), and VIC (stx2).
3. Results
During the study period, 47 fecal broth enrichments that
tested positive for Stx by EIA at clinical diagnostic
laboratories in Washington state were sent to WAPHL for
confirmation and isolation of STEC. Stx test was repeated at
WAPHL using ImmunoCard STAT!EHEC to confirm the
presence of either Stx 1 or 2, or both, in each specimen
submitted. Subsequently, conventional culture and experi-
mental acid enrichment methods were used in parallel for the
isolation of STEC from the fecal broth cultures. A
comparison of the results from the 2 methods is shown in
Table 1. A total of 32 STEC isolates were identified from the
47 specimens tested using both methods. However, the acid
enrichment method produced STEC from an additional 11
specimens. Conversely, STEC from one specimen was
recovered by the conventional method but not by the acid
enrichment protocol. The sample was determined as STEC
negative when a total of 20 colonies were Stx-EIA negative
and stx1/stx2-PCR negative. Overall, acid enrichment
recovered STEC from 43 (91%) of 47 specimens, while
conventional culture recovered STEC from 33 specimens
(70%). Three specimens did not produce STEC isolates by
either method. Direct real-time PCR analysis on the 3 fecal
broth enrichments, as well as on the colony sweeps from
MAC, SMAC, RTN, and TCSMAC agar plates, produced
negative results for stx1 andstx2.
The bacterial growth on SMAC, RTN, and TC-SMAC
was compared between conventional culture and acid
enrichment methods. It was noted that use of the acid
method typically reduced the background population as
shown in Fig. 1.
Thirty-six of the forty-four STEC were identified to
specific serogroups. Eleven were O26, 9 were O157, and 7
were O103. The remaining 9 STEC represent 6 different
serogroups (see Table 1). One STEC was identified by
polyvalent antisera, which contained O44, O55, O125,
O126, O146, and O166. Seven STEC were difficult to
serogroup, and the results are still pending during the
preparation of this manuscript. However, the laboratory
testing indicated that they belonged to non-O157 STEC
based on the appearance of the colonies on SMAC or
TCSMAC agar plates (sorbitol-positive) and negative
reaction against O157 antisera. In summary, of the 44 fecal
broth cultures, 9 contained E. coli O157 and 35 contained
non-O157 STEC.
Analysis of the STEC by real-time PCR indicated that all
E. coli O157 (100%) contained stx2 genes, 7 of them (78%)
contained both stx1 and stx2, and none contained stx1 alone.
Of the non-O157 STEC, 24 contained stx1 only (69%), 6
contained stx2 only (17%), and 5 contained both stx1 and
stx2 (14%).
For quantitative comparison of enrichment protocols, 6
additional broth cultures that were Stx-positive by EIAwere
enriched overnight in GN broth and by the acid enrichment
(Fig. 2). As shown in Table 2, greater numbers of stx-
containing cells were generated in 4 of 6 specimens with the
acid method, as indicated by lower Ct values and larger
viable counts. In specimens 14666 and 14678, low Ct values,
indicating large target populations, were obtained from both
enrichment methods. An stx1-containing E. coli was isolated
from 14449 in addition to an stx1-containing Enterobacter
sp. This isolate was identified as E. cloacae by API20E
(bioMerieux, Durham, NC), E. hormaechei by Biolog
(Biolog Inc., Hayward, CA), and E. sakazakii by 16S
DNA sequencing. Enterobacter sp. harboring Stx has been
reported, though infrequently, and the lack of agreement by
different identification procedures may reflect horizontal stx
gene transfer among different species (Herold et al., 2004).
4. Discussion
The purpose of the study was to determine the utility of
the acid enrichment method and to compare it with
conventional culture methods for the isolation of STEC.
The WAPHL protocol routinely picked 10 sorbitol/lactose-
fermenting colonies from SMAC and/or MAC agars to
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screen for potential non-O157 STEC by ImmunoCard STAT!
EHEC or Premier™ EHEC if a large number of specimens is
to be tested. The number of Stx-positive colonies out of 10
varied depending on the samples. In many cases, the first set
of 10 sorbitol/lactose-fermenting colonies was not sufficient
to recover non-O157 STEC, and additional 10 colonies was
needed to be tested for Stx. This isolation process is time-
consuming and costly.
Table 1
Recovery of STEC from fecal swabs













1 Pale + + Gray Pink 1 Poly 2d
2 Pink − + Gray/black Pink 1 O26
3 Pink + − Light gray Pink 2 O28AC:H25
4 Pink − + Purple Pink 1 O26
5 Pink/pale + + Gray/black Pale 2 O157
6 Pink + + Purple Pink 1 O26:H11
7 Pink/pale − + Purple Pink 1 O111
8 Pink − + Magenta Pink 2 Pending
9 Pale + + Gray/black Pink 1 and 2 O157:H7
10 Pink + + Purple Pink 1 O111
11 Pink − − No growth No growth Negative
12 Pink + Yes Grayish Pink 2 O121:H19
13 Pink/pale + Yes Blue-gray Pale 1&2 O157
14 Pink − − No growth No growth Negative
15 Pink/pale − − No growth No growth Negative
16 Pink + + Magenta Pink 1 and 2 O26
17 Pink + + Purple Pink 1 and 2 O26
18 Pink + + Light pink Pink 1 O103:H2
19 Pink + + No growth Pink 1 O146
20 Pale + + Dark gray Pale 1 and 2 O157
21 Pink + + Gray Pink 1 O26:H11
22 Pale + + Gray-black Pink 2 O157
23 Pink + + Pale Pink 2 Pending
24 Pink + + Pink/gray Pink 1 O26
25 Pink + + Pink/gray Pink 1 Pending
26 Pink − + Gray Pink 1 and 2 O26
27 Pink + + Gray Pink 1 O26:H11
28 Pink + + Magenta Pink 1 and 2 O:NM
29 Pink + + Purple Pink 1 O103:H11
30 Pink + + Purple Pink 1 O26:H11
31 Pink + + Gray Pink 1 O103:H2
32 Pink/pale + + Dark blue/black Pink 1 and 2 O157:H7
33 Pink − + Purple Pink 1 O26:H11
34 Pink + + Pink Pink 2 O121:H19
35 Pink − + Purple Pink 1 O103:H2
36 Pink + + Light purple Pink 1 O103:H2
37 Pink + + Purple Pink 1 O103:H2
38 Pink + + Pink Pink 2 O121:H19
39 Pink/pale + + Dark blue/black Pink 1 and 2 O157:H7
40 Pink + + Blue/gray Pink 1 Pending
41 Pink − + Dark blue/black Pink 1 and 2 O157:H7
42 Pink − + Purple Pink 1 O103:H2
43 Pink/pale + + Dark blue/black Pink 1 and 2 O157:H7
44 Pink + + Purple Pink 1 Pending
45 Pink − + Magenta Pink 1 O76:H19
46 Pink − + No growth Pink 1 and 2 Pending
47 Pink + + Purple Pink 1 Pending
Total 33 43
Conventional versus acid enrichment with 42 °C incubation.
a Up to 20 colonies picked from MacConkey–sorbitol agar (MS) and tested for Stx activities using ImmunoCard STAT!HEHC or Premier ™ EHEC by
Meridian. Biochemical tests were then performed on the STEC positives.
b PCR conducted on colonies picked from RTN, TCSMAC, or MacConkey–sorbitol.
c Serotypes of the E. coli isolates are determined either using antisera produced by the Statens Serum Institut/MiraVista Diagnostics in the Washington
state lab or tested by CDC.
d Polyvalent 2 includes O44, O55, O125, O126, O146, O166.
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The data indicated that the acid enrichment method
increased the recovery of STEC by 21% increase in the
recovery of STEC when compared with the conventional
culture method. The lower recovery rate by conventional
culture is probably due to the lower levels of STEC in the
samples. The fecal broths included in the studies came from
multiple clinical laboratories across the Washington state and
represented a diverse patient population. In addition, many
of the samples were already screened by the submitting
laboratories for STEC, and the difficult-to-identify samples
were then sent to the state lab for further analysis.
Furthermore, the review of the sample submission forms
revealed that the samples were delayed as long as up to 13
days in submitting to the WAPHL, which may reduce the
number of viable STEC that were mixed within the common
microflora and thus affect the isolation of STEC by
conventional culture method. The acid shock/treatment
combined with incubation at 42 °C can greatly reduced the
competing microflora in fecal broths and therefore enhance
the detection of STEC. In our parallel study, we compared
the number of colonies on SMAC with those on RTN and
TCSMAC and noticed that the selective agars streaked after
the acid enrichment step often exhibit many more target
colonies than with the conventional method. The decreased
level of normal microflora and enhanced targeted colonies
made the isolation of STEC much easier and more sensitive.
These results are in agreement with earlier studies
indicating that acid enrichment is comparable or better
than several standard STEC enrichment procedures using
food and wastewater samples. Earlier and recent work also
demonstrated that variants of the acid enrichment protocol
were effective with numerous STEC strains. From those
studies, 53 of 53 STEC including O157 were enriched
from approximately 1 CFU mL−1 to approximately 1 × 109
CFU mL−1 after overnight incubation (Grant, 2004, 2005;
and unpublished data). These data would suggest that the
acid enrichment procedure (Grant, 2005), as described in
this study, followed by neutralization with TYTP and
incubation at 42 °C, is an effective strategy with which to
improve the culture and subsequent detection of STEC
from clinical specimens.
Three positive Stx EIA results from fecal broths without
STEC present a dilemma. STEC may have been present in
these 3 EIA-positive broths, but alternatively, the EIA signal
might have represented a false-positive test, as has been
reported (Anonymous, 2006).
Of the 44 STEC culture, 9 were E. coli O157 (20%) and
35 belonged to non-O157 STEC (79%). The number of non-
Table 2
Real-time PCR detection of stx1 and stx2 after overnight enrichment of
presumptive positive fecal specimens by acid or GN broth methods




Acid enriched 28.1a 28.4 2.0 × 107 E. coli 5144172
GN enriched 34.7 34.6 b5 × 106 ND
14449
Acid enriched 23.3 ND 1.3 × 107 E. coli 5144572b
GN enriched 30.5 ND b5 × 106 ND
14556
Acid enriched 22.4 ND 2.7 × 108 E. coli 5144562
GN enriched 34.5 ND b5 × 106 ND
14644
Acid enriched 22.9 ND 8.6 × 107 E. coli 5144562
GN enriched ND ND b5 × 105 ND
14666
Acid enriched ND 20.6 1.8 × 108 E. coli 5144572
GN enriched ND 23.2 2.6 × 108 E. coli 5144572
14678
Acid enriched 23.2 23.1 1.2 × 107 E. coli 5144542
GN enriched 23.2 22.4 2.7 × 108 E. coli 5144542
ND = not detected.
a Ct values are means of duplicate analyses. Ct values of 35–22
correspond to viable counts of 1 × 105–5 × 108.
b In addition to E. coli, a stx-positive Enterobacter sp. (API 3305573)
was isolated from this sample.
Fig. 1. Recovery of E. coli O157 on RTN agar from specimen 5 (Table 1)
after acid enrichment.
Fig. 2. Recovery of E. coli O26 on TCSMAC agar from 14644 (Table 2)
after GN broth enrichment (L) or acid enrichment (R).
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O157 STEC is significantly higher than E. coli O157.
However, the ratio of the non-O157 versus O157 STEC in
this study does not necessarily reflect the prevalence of non-
O157 STEC in Washington state due to the inadequate
number of samples analyzed. Among the non-O157 STEC
identified in this report, the most common serogroups was
O26 (30.6%), consistent with the national data as reported by
Brooks et al. (2005).
It is reported that the virulence gene stx2 was significantly
associated with an increased risk of HUS in persons with
non-O157 STEC (Brooks et al., 2005; Jenkins et al., 2003).
About one-third (31%) of the non-O157 STEC identified in
this study contained either stx2 gene alone or in combination
with stx1. The association of stx2-containing STEC with the
severity of diseases remains unknown since limited clinical
information is available.
The findings in this study demonstrated that the use of an
acid enrichment protocol in conjunction with incubation at
42 °C increased STEC detection in fecal specimens. The
most beneficial effect of the acid protocol with 42 °C
incubation was to lower colony background on selective
agars and therefore reduce the possibility of false-negative
results due to low numbers of target cells being obscured by
the heavy growth of competitors.
The acid enrichment step when combined with the use of
TCSMAC agar is a simple and cost-effective method that
can be easily applied in clinical laboratories to improve the
detection and isolation of STEC. The reduced background
of normal flora greatly enhances the recovery of lower
levels of STEC in fecal specimens. Use of sensitive and
efficient culture confirmation can expedite serotyping and
subtyping of isolates and detection of both O157 and non-
O157 SETC outbreaks.
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